Paper Details 
Original Abstract of the Article :
OBJECTIVE: We explored the efficacy and safety profile of cenobamate as an adjunctive therapy in patients with refractory focal-onset epilepsy in the pediatric population. METHODS: This was a retrospective, single-center study of cenobamate used as an adjunctive medication in pediatric patients wit...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.yebeh.2022.108679

データ提供:米国国立医学図書館(NLM)

Adjunctive Use of Cenobamate for Pediatric Refractory Focal-Onset Epilepsy

This study, a true beacon in the often-murky waters of epilepsy research, focuses on the potential of cenobamate as an adjunctive therapy for pediatric patients with refractory focal-onset epilepsy. The authors, like intrepid explorers charting unknown territories, delved into the complex world of epilepsy in children, seeking a path to improved seizure control. Employing a retrospective, single-center study design, they carefully analyzed data on cenobamate's efficacy and safety profile in this specific patient population. Their findings, like a refreshing spring in a dry landscape, offer insights into the potential of cenobamate to improve seizure control and quality of life for these young patients. The study concluded that cenobamate demonstrates similar efficacy rates and safety profiles within the pediatric population compared to adult data, making it a promising adjunctive medication for children with refractory focal-onset epilepsy.

Hope for Young Patients with Epilepsy

This research offers a ray of hope for families of children with epilepsy. The study's findings suggest that cenobamate, when used as an adjunctive therapy, can significantly reduce seizure frequency and potentially even achieve seizure freedom in some patients. These results, like a cool breeze in a scorching desert, offer much-needed relief and hope to those struggling with epilepsy.

Navigating the Challenges of Epilepsy

Epilepsy, like a desert storm, can wreak havoc on individuals and their families. Understanding the potential benefits of cenobamate in managing epilepsy in children can empower families to better understand their child's condition and work with their healthcare providers to develop personalized treatment plans. This research serves as a valuable resource for families navigating the often-turbulent landscape of epilepsy.

Dr.Camel's Conclusion

This study underscores the importance of continued research in pediatric epilepsy. The authors' dedication to finding new solutions for children battling this complex disorder is truly inspiring. It's a reminder that even in the most challenging of circumstances, there is always hope for progress and improvement.

Date :
  1. Date Completed 2022-05-04
  2. Date Revised 2022-07-01
Further Info :

Pubmed ID

35381496

DOI: Digital Object Identifier

10.1016/j.yebeh.2022.108679

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.